The Paul-Ehrlich-Institut, on behalf of the COMBINE project, is organising a two-day, free, virtual workshop to discuss recurring challenges and possible mitigation strategies in the development of monoclonal antibodies (mAbs) for AMR pathogens. The workshop is open to industry, academia, research institutes, regulatory and public health bodies. Please forward the invitation to interested colleagues and partners.
Day 1 (Wednesday June 8th, 15.00-18.00 CEST / 9.00-12.00 EDT): Motivation and focus on preclinical development and translation
Agenda:
15.00-15.10 Introduction
15.10-15.50 mAbs for AMR pathogens: where are we?
15.50-16.00 Biobreak
16.00-17.50 Focus on preclinical development and translation
17.50-18.00 Wrap up
Register here
Day 2 (Thursday June 9th, 15.00-18.00 CEST / 9.00-12.00 EDT): Focus on recurring problems and mitigation strategies in the clinical development
Agenda:
15.00-15.10 Introduction
15.10-16.50 Focus on recurring problems in the clinical development
16.50-17.00 Biobreak
17.00-17.50 Focus on mitigation strategies in the clinical development
17.50-18.00 Wrap up
Register here
Help them tailor the workshop to your needs by participating in this short survey
In case of questions, please contact imi-combine@pei.de
